Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
About the drug: Linagliptin is an oral diabetes drugs that helps in managing glucose levels.Medicinal characteristics that setslinagliptin aside from different DPP-4 inhibitors is that it's a non-linear pharmacokinetic profile and isn't primarily eliminated by the urinary organ system.